Cita APA

Canella, A., Nieves, H. C., Sborov, D. W., Cascione, L., Radomska, H. S., Smith, E., . . . Pichiorri, F. (2015). HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide. Oncotarget.

Chicago Style Citation

Canella, Alessandro, et al. "HDAC Inhibitor AR-42 Decreases CD44 Expression and Sensitizes Myeloma Cells to Lenalidomide." Oncotarget 2015.

Cita MLA

Canella, Alessandro, et al. "HDAC Inhibitor AR-42 Decreases CD44 Expression and Sensitizes Myeloma Cells to Lenalidomide." Oncotarget 2015.